Suppr超能文献

一种高效的短发夹 RNA 可在 hu-BLT 小鼠模型的全身淋巴器官中有效下调 CCR5 的表达。

A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.

机构信息

Department of Medicine, Division of Hematology-Oncology, UCLA AIDS Institute, David Geffen School of Medicine, University of California-Los Angeles, 615 Charles E. Young Drive South, Los Angeles, CA 90095, USA.

出版信息

Blood. 2010 Feb 25;115(8):1534-44. doi: 10.1182/blood-2009-04-215855. Epub 2009 Dec 17.

Abstract

Inhibiting the expression of the HIV-1 coreceptor CCR5 holds great promise for controlling HIV-1 infection in patients. Here we report stable knockdown of human CCR5 by a short hairpin RNA (shRNA) in a humanized bone marrow/liver/thymus (BLT) mouse model. We delivered a potent shRNA against CCR5 into human fetal liver-derived CD34(+) hematopoietic progenitor/stem cells (HPSCs) by lentiviral vector transduction. We transplanted vector-transduced HPSCs solidified with Matrigel and a thymus segment under the mouse kidney capsule. Vector-transduced autologous CD34(+) cells were subsequently injected in the irradiated mouse, intended to create systemic reconstitution. CCR5 expression was down-regulated in human T cells and monocytes/macrophages in systemic lymphoid tissues, including gut-associated lymphoid tissue, the major site of HIV-1 replication. The shRNA-mediated CCR5 knockdown had no apparent adverse effects on T-cell development as assessed by polyclonal T-cell receptor Vbeta family development and naive/memory T-cell differentiation. CCR5 knockdown in the secondary transplanted mice suggested the potential of long-term hematopoietic reconstitution by the shRNA-transduced HPSCs. CCR5 tropic HIV-1 infection was effectively inhibited in mouse-derived human splenocytes ex vivo. These results demonstrate that lentiviral vector delivery of shRNA into human HPSCs could stably down-regulate CCR5 in systemic lymphoid organs in vivo.

摘要

抑制 HIV-1 核心受体 CCR5 的表达为控制患者体内 HIV-1 感染带来了巨大的希望。在这里,我们报告了短发夹 RNA(shRNA)在人源化骨髓/肝/胸腺(BLT)小鼠模型中稳定敲低人 CCR5 的情况。我们通过慢病毒载体转导将针对 CCR5 的强效 shRNA 递送至人胎肝来源的 CD34(+)造血祖细胞/干细胞(HPSC)。我们将转导载体的 HPSC 与 Matrigel 和胸腺节段一起固化在小鼠肾脏包膜下。随后将转导的自体 CD34(+)细胞注入辐照小鼠中,旨在进行全身重建。CCR5 表达在全身淋巴组织中的人 T 细胞和单核细胞/巨噬细胞中下调,包括肠道相关淋巴组织,这是 HIV-1 复制的主要部位。通过多克隆 T 细胞受体 Vbeta 家族发育和幼稚/记忆 T 细胞分化评估,shRNA 介导的 CCR5 敲低对 T 细胞发育没有明显的不良影响。在二次移植的小鼠中,CCR5 敲低表明转导 HPSC 的 shRNA 具有长期造血重建的潜力。在体外,CCR5 嗜性 HIV-1 感染在小鼠来源的人脾细胞中被有效抑制。这些结果表明,shRNA 可以通过慢病毒载体递送至人 HPSC 中,从而在体内稳定下调全身淋巴器官中的 CCR5。

相似文献

1
7
RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice.
Mol Ther Nucleic Acids. 2015 Feb 17;4(2):e227. doi: 10.1038/mtna.2015.3.
8
RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
Mol Ther. 2002 Dec;6(6):770-82. doi: 10.1006/mthe.2002.0800.

引用本文的文献

3
Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection.
Mol Ther Methods Clin Dev. 2025 May 15;33(2):101486. doi: 10.1016/j.omtm.2025.101486. eCollection 2025 Jun 12.
4
Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection.
bioRxiv. 2024 Nov 13:2024.11.13.623476. doi: 10.1101/2024.11.13.623476.
8
Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G.
Mol Ther Nucleic Acids. 2023 Aug 11;33:794-809. doi: 10.1016/j.omtn.2023.08.007. eCollection 2023 Sep 12.

本文引用的文献

1
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition.
Mol Ther. 2008 Mar;16(3):557-564. doi: 10.1038/sj.mt.6300382. Epub 2016 Dec 8.
2
Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5.
Genet Vaccines Ther. 2009 Jun 10;7:8. doi: 10.1186/1479-0556-7-8.
3
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
N Engl J Med. 2009 Feb 12;360(7):692-8. doi: 10.1056/NEJMoa0802905.
4
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.
Cell. 2008 Aug 22;134(4):577-86. doi: 10.1016/j.cell.2008.06.034. Epub 2008 Aug 7.
8
Titers of HIV-based vectors encoding shRNAs are reduced by a dicer-dependent mechanism.
Mol Ther. 2008 Feb;16(2):378-86. doi: 10.1038/sj.mt.6300370. Epub 2007 Dec 11.
9
Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters.
Gene Ther. 2007 Nov;14(21):1503-12. doi: 10.1038/sj.gt.3303011. Epub 2007 Sep 6.
10
Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates.
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13110-5. doi: 10.1073/pnas.0705474104. Epub 2007 Aug 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验